Scibase News

Skip to content

Products
Nevisense Platform
- Nevisense Platform
Nevisense Go
Sign up to our newsletter
Applications
Indications
- Melanoma skin cancer
- Keratinocyte cancer detection
Research
- Skin barrier
- Cosmetic testing
Sign up to our newsletter
About us
About us
- Mission & Vision
- Career
Governance
- Management
- Board of directors
Sign up to our newsletter
Contact
Contact
- Book a demo
- Find clinics
Sign up to our newsletter

First Patient in New Study Assessing early prediction of flares

First Patient in New Study Assessing early prediction of flares

2026-06-23

The primary objective of the multicenter prospective clinical study is to assess the prediction of f...

SciBase reaches milestone with over 400,000 tests sold with Nevisense

2026-06-17

Nevisense is the only FDA-approved and CE-marked non-invasive diagnostic technology used by dermatol...

Scibase Product

Test entry

2026-05-23

some text...